PRA Group, Inc. — Q1 2024 Form 10-Q
Reporting period: Three months ended March 31, 2024; financial statements are unaudited. PRA Group buys, collects and manages nonperforming loan portfolios across the Americas, Europe and Australia, and also provides U.S. class-action claims recovery services. Dollar amounts below are in millions unless noted.
Financial performance and key metrics
| Metric | Q1 2024 | Q1 2023 | Change / context |
|---|---|---|---|
| Total revenue | $255.6 | $155.5 | Up 64.4% |
| Portfolio income | $202.1 | $188.2 | Up 7.3% |
| Change in expected recoveries | $51.7 | $(36.9) | $88.6 improvement |
| Operating expenses | $189.2 | $189.1 | Essentially flat |
| Operating income (loss) | $66.4 | $(33.6) | Operating margin: 26.0% vs. (21.6%) |
| Interest expense, net | $52.3 | $38.3 | Up 36.6% |
| Net income (loss) attributable to PRA Group | $3.5 | $(58.6) | Net margin: 1.4% vs. (37.7%) |
| Diluted EPS | $0.09 | $(1.50) | Returned to profitability |
| Cash collections | $449.5 | $411.3 | Up 9.3% |
| Portfolio purchases | $245.8 | $230.2 | Up 6.8% |
| Estimated remaining collections (ERC) | $6,498.2 | $5,674.7 | Up $823.5 year over year |
- Changes in expected recoveries included $35.8 million of collections above forecast and a $15.8 million increase in expected future recoveries. Management attributed overperformance largely to U.S. collections initiatives and tax-refund seasonality, with contributions from Brazil and Europe.
- Cash efficiency ratio was 58.0%, compared with 54.3%. This company-defined measure is cash receipts less operating expenses, divided by cash receipts.
- Operating cash flow was $(73.0) million, versus $(47.5) million. Investing cash flow was $15.2 million and financing cash flow was $52.8 million. Cash, cash equivalents and restricted cash ended at $109.6 million; balance-sheet cash and cash equivalents were $108.1 million.
- Cash paid for interest was $76.7 million, compared with $25.1 million. Management cited higher interest payments and lower accrued expenses among the factors behind increased operating cash use.
Balance sheet, debt and liquidity
- At March 31, 2024, total assets were $4.48 billion, finance receivables net were $3.65 billion, and total liabilities were $3.29 billion. Finance receivables were down $6.4 million from year-end 2023, while borrowings rose to $2.95 billion from $2.91 billion.
- Borrowings comprised revolving facilities, a $437.5 million term loan and $1.046 billion of senior notes. Senior notes mature in 2025, 2028 and 2029. The company reported compliance with financing covenants at quarter-end.
- Credit-facility availability was $1.22 billion in total, including $366.9 million based on current ERC and $855.2 million of additional availability subject to borrowing bases and covenants. Cash and cash equivalents were $108.1 million; $96.6 million was held in international operations with indefinitely reinvested earnings.
- Debt to Adjusted EBITDA, a non-GAAP measure, was 2.83x, versus 2.89x at December 31, 2023. Adjusted EBITDA for the last twelve months was $1.04 billion; the company reported a last-twelve-month net loss attributable to PRA Group of $21.4 million.
- Approximately 60% of total debt was fixed-rate or converted to fixed-rate through hedges. Management estimated that a 50-basis-point rate increase would raise interest expense over the following 12 months by $6.1 million, based on the quarter-end debt structure.
Changes versus the prior-year quarter
- Revenue and operating results improved substantially, principally because expected-recovery adjustments shifted from a $36.9 million reduction in Q1 2023 to a $51.7 million increase in Q1 2024. Cash collections rose 9.3%, with growth in U.S. Core, Europe and Brazil.
- Operating expenses were nearly unchanged. Compensation expense fell $8.8 million, partly because Q1 2023 included $7.5 million of severance costs; legal collection fees, legal collection costs, agency fees and communications expense increased.
- Net interest expense increased $14.0 million, primarily from higher average debt balances and interest rates. Q1 2023 financing cash flow included $400 million of proceeds from the 2028 Notes issuance; there was no comparable issuance in Q1 2024.
- Foreign currency translation reduced Q1 2024 comprehensive income by $48.2 million, contributing to a $43.1 million increase in accumulated other comprehensive loss during the quarter.
Outlook, risks and contingencies
- No specific earnings or revenue guidance was provided. Management said it expects strong U.S. portfolio investment to continue, and expects Q2 European investment to align more closely with long-term trends as market volumes improve. It also cited fewer large one-time payments in some U.S. and European markets, while customer engagement and payment rates remained fairly steady.
- Management emphasized disciplined portfolio pricing and a profitability plan focused on increasing ERC and portfolio returns, improving collection execution, and optimizing costs. It reported the second-highest Q1 U.S. investment level in company history.
- Estimated forward-flow purchases over the next 12 months were approximately $473.9 million, based on projections and seller delivery; purchases may vary significantly. The filing says minimum contractual purchase obligations under these agreements were not significant.
- Key disclosed risks include economic deterioration, collection performance and portfolio availability/pricing, regulatory or legal restrictions on collections, interest and foreign-exchange movements, financing access and covenant compliance, litigation and regulatory actions, cybersecurity and third-party service disruptions, and potential goodwill impairment. The company said its March 31, 2024 assessment found no goodwill impairment trigger, but identified its debt-buying and collection reporting unit as potentially at risk if cash-flow projections or market factors deteriorate.
- Legal and regulatory matters arise in the ordinary course. The company said there were no new material proceedings or material developments in previously reported proceedings during the quarter, and estimated reasonably possible losses beyond accruals were not material where estimable; actual losses could exceed estimates.
- Forward-looking statements are subject to uncertainty. The company stated that risk factors were not materially changed from its 2023 Form 10-K. Disclosure controls were assessed as effective, with no material change in internal control over financial reporting reported for the quarter.
Important facts for investors to verify
- How much of the revenue and earnings improvement is sustained portfolio income and collections performance versus estimate-sensitive changes in expected recoveries.
- Whether collection overperformance and ERC estimates persist after seasonal tax-refund effects, and how new portfolio cohorts perform relative to purchase assumptions.
- Whether higher interest expense, debt levels and borrowing-base availability constrain portfolio investment or profitability.
- Whether management’s expected improvement in European market volumes and continued U.S. purchasing opportunities materialize, and at what acquisition prices and returns.
- Future developments in legal, regulatory, tax and goodwill-impairment exposures, including the judgment involved in portfolio cash-flow and valuation estimates.